Status:
RECRUITING
The VESPA Pilot Study
Lead Sponsor:
Wake Forest University
Collaborating Sponsors:
Wells Fargo Faculty Scholar Endowment
Conditions:
Exercise
Behavior
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
Physical activity has been described by the US federal government as a 'best buy' for public health. Unfortunately, most adults in the United States are not sufficiently active, and this worsens with ...
Eligibility Criteria
Inclusion
- Age of 45-80 years
- Body mass index between 30-45 kg/m2
- Low-active (30 or more minutes of moderate intensity physical activity on 2 or fewer days per week)
- Have access to home Wi-Fi
- Have regular access to a computer, tablet, or smartphone to receive teleconferencing calls
- Have a clear "VR space" (7'x7' object-free space)
- Have an "Activity buddy" (spouse, child, caregiver, etc.)
- Modified Telephone Interview for Cognitive Status (TICS-M) score of 32 or greater
- Consent from a physician for study participation
- Proficient in the English language
- Willingness to create or use existing personal Facebook account for virtual reality activities.
Exclusion
- Current involvement in other physical activity research studies
- Hearing or sight impairments (significant visual or hearing impairment that cannot be corrected and results in the inability to use the telephone or hear normal conversation, colorblindness)
- Dependence on a cane or walker
- More than 1 fall in the past year
- Contraindication to exercise
- Current or recent history within the last 6 months of: symptomatic coronary heart disease, cancer, liver or renal disease, severe pulmonary disease, gross physical impairment, or uncontrolled hypertension; myocardial infarction or cardiovascular procedure within the last 3 months
- History of or diagnosis of photosensitive epilepsy
- Score of "severe" on any question in the Virtual Reality Sickness Questionnaire;
- Unwillingness to use a head-mounted virtual reality system
- Current severe or untreated depression
Key Trial Info
Start Date :
December 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04756245
Start Date
December 17 2020
End Date
December 30 2026
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University
Winston-Salem, North Carolina, United States, 27109